Chinese Pharma Tycoon Looks For Overseas Health-Care Deals

  • Luye Group seeks to buy hospitals overseas to gain new brands
  • Liu wants to tap rising Chinese demand for better health care

Liu Dian Bo.

Photographer: Charles Pertwee/Bloomberg

Liu Dian Bo, chairman of China’s Luye Group Ltd., is on a hunt for health-care businesses to acquire overseas as he seeks to expand beyond pharmaceuticals and tap rising demand from more affluent Chinese for higher-quality services.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.